Home » Topics » BioWorld Science

BioWorld Science
RSS

Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors

Oct. 14, 2021

Overcoming EGFR-targeted TKI lung cancer resistance

Oct. 14, 2021

Vaxil reports data on P-Esbp-DOX in mouse model of aggressive liver metastasis of colorectal tumors

Oct. 13, 2021

BridgeBio reports highlights from preclinical cancer and gene therapy pipelines

Oct. 13, 2021

Emmaus gains license to Kainos' novel IRAK-4 inhibitor KM-10544

Oct. 13, 2021

Preclinical data support use of ibrexafungerp to treat mucormycosis

Oct. 13, 2021

NCI grant supports development of ST-316 to treat Wnt/beta-catenin-dependent breast cancer

Oct. 13, 2021

Liver TR-beta1 activation can alleviate nonalcoholic steatohepatitis

Oct. 13, 2021

NV-CoV-2 effective against SARS-CoV-2 in standard cell culture pseudovirion assay

Oct. 13, 2021

Kallistatin is a marker of NAFLD progression in patients with hypertension

Oct. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...